Cumberland Short Long Term Debt vs Capital Stock Analysis
CPIX Stock | USD 1.48 0.03 2.07% |
Cumberland Pharmaceuticals financial indicator trend analysis is way more than just evaluating Cumberland Pharmaceuticals prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cumberland Pharmaceuticals is a good investment. Please check the relationship between Cumberland Pharmaceuticals Short Long Term Debt and its Capital Stock accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cumberland Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Cumberland Stock please use our How to Invest in Cumberland Pharmaceuticals guide.
Short Long Term Debt vs Capital Stock
Short Long Term Debt vs Capital Stock Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cumberland Pharmaceuticals Short Long Term Debt account and Capital Stock. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Cumberland Pharmaceuticals' Short Long Term Debt and Capital Stock is -0.18. Overlapping area represents the amount of variation of Short Long Term Debt that can explain the historical movement of Capital Stock in the same time period over historical financial statements of Cumberland Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Cumberland Pharmaceuticals' Short Long Term Debt and Capital Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt of Cumberland Pharmaceuticals are associated (or correlated) with its Capital Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Stock has no effect on the direction of Short Long Term Debt i.e., Cumberland Pharmaceuticals' Short Long Term Debt and Capital Stock go up and down completely randomly.
Correlation Coefficient | -0.18 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Short Long Term Debt
The total of a company’s short-term and long-term borrowings.Capital Stock
The total amount of a company’s capital funded by shareholders through the issue and subscription of shares.Most indicators from Cumberland Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cumberland Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cumberland Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Cumberland Stock please use our How to Invest in Cumberland Pharmaceuticals guide.Discontinued Operations is likely to rise to about 2.4 M in 2024, whereas Selling General Administrative is likely to drop slightly above 8.9 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 98.0K | 586.0K | 667.9K | 701.3K | Depreciation And Amortization | 6.8M | 5.4M | 5.8M | 6.1M |
Cumberland Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Cumberland Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cumberland Pharmaceuticals fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 104.5M | 96.5M | 84.5M | 92.9M | 81.8M | 88.1M | |
Short Long Term Debt Total | 21.5M | 17.1M | 16.1M | 21.0M | 18.4M | 11.9M | |
Other Current Liab | 7.7M | 11.3M | 8.7M | 17.6M | 13.6M | 7.8M | |
Total Current Liabilities | 24.2M | 25.7M | 19.3M | 28.6M | 28.0M | 16.8M | |
Total Stockholder Equity | 51.1M | 47.0M | 42.8M | 36.3M | 29.6M | 58.3M | |
Property Plant And Equipment Net | 3.7M | 2.6M | 1.5M | 5.5M | 7.0M | 7.4M | |
Net Debt | (6.7M) | (7.7M) | (11.0M) | 1.2M | 106.9K | 112.2K | |
Retained Earnings | 1.2M | (2.1M) | (5.6M) | (11.2M) | (17.5M) | (16.6M) | |
Accounts Payable | 10.0M | 13.4M | 9.6M | 10.8M | 14.0M | 14.7M | |
Cash | 28.2M | 24.8M | 27.0M | 19.8M | 18.3M | 27.3M | |
Non Current Assets Total | 54.4M | 46.5M | 38.8M | 47.1M | 46.1M | 27.5M | |
Cash And Short Term Investments | 28.2M | 24.8M | 27.0M | 19.8M | 18.3M | 31.1M | |
Net Receivables | 7.9M | 12.4M | 6.9M | 13.2M | 9.8M | 7.4M | |
Common Stock Shares Outstanding | 15.4M | 15.2M | 14.9M | 14.6M | 14.3M | 13.5M | |
Liabilities And Stockholders Equity | 104.5M | 96.5M | 84.5M | 92.9M | 81.8M | 88.1M | |
Non Current Liabilities Total | 29.3M | 23.9M | 22.6M | 28.4M | 24.5M | 13.1M | |
Inventory | 8.9M | 10.6M | 8.4M | 9.4M | 4.6M | 7.3M | |
Other Current Assets | 2.8M | 2.2M | 3.3M | 3.5M | 3.0M | 2.3M | |
Other Stockholder Equity | 2.9M | 3.1M | 3.4M | (212.3K) | (244.2K) | (256.4K) | |
Total Liab | 53.5M | 49.6M | 41.9M | 57.0M | 52.5M | 29.9M | |
Property Plant And Equipment Gross | 3.7M | 2.6M | 1.5M | 5.5M | 9.3M | 9.7M | |
Total Current Assets | 50.2M | 50.0M | 45.7M | 45.9M | 35.7M | 60.5M | |
Intangible Assets | 30.9M | 28.1M | 24.0M | 30.6M | 22.6M | 19.2M | |
Non Currrent Assets Other | 18.9M | 14.9M | 12.5M | 10.0M | 15.5M | 16.3M | |
Other Liab | 8.7M | 7.9M | 7.5M | 7.6M | 8.7M | 9.2M | |
Other Assets | 18.9M | 17.8M | 12.5M | 10.0M | 11.6M | 7.4M | |
Long Term Debt | 20M | 18.5M | 15M | 16.2M | 12.8M | 9.3M | |
Common Stock | 49.9M | 49.1M | 48.5M | 47.5M | 47.1M | 44.7M | |
Property Plant Equipment | 16.3M | 12.2M | 1.5M | 5.5M | 6.3M | 6.6M | |
Net Tangible Assets | 19.3M | 18.0M | 18.0M | 4.8M | 4.3M | 4.1M | |
Noncontrolling Interest In Consolidated Entity | (198.6K) | (274.3K) | (37.6K) | (117.1K) | (105.4K) | (110.7K) | |
Common Stock Total Equity | 52.4M | 51.1M | 49.9M | 49.1M | 44.2M | 46.2M | |
Retained Earnings Total Equity | 11.7M | 4.7M | 1.2M | (2.1M) | (1.9M) | (1.8M) | |
Long Term Debt Total | 9.8M | 20M | 18.5M | 15M | 17.3M | 10.8M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cumberland Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cumberland Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cumberland Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cumberland Pharmaceuticals Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cumberland Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Cumberland Stock please use our How to Invest in Cumberland Pharmaceuticals guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Complementary Tools for Cumberland Stock analysis
When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is Cumberland Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cumberland Pharmaceuticals. If investors know Cumberland will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cumberland Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.59) | Revenue Per Share 2.728 | Quarterly Revenue Growth (0.08) | Return On Assets (0.05) | Return On Equity (0.27) |
The market value of Cumberland Pharmaceuticals is measured differently than its book value, which is the value of Cumberland that is recorded on the company's balance sheet. Investors also form their own opinion of Cumberland Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Cumberland Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cumberland Pharmaceuticals' market value can be influenced by many factors that don't directly affect Cumberland Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cumberland Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cumberland Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cumberland Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.